Retrospective study evaluates potassium sodium hydrogen citrate's impact on stent encrustation, suggesting improved outcomes.
BACKGROUND: Double-J (DJ) ureteral stent encrustation is a frequent complication after ureteroscopic lithotripsy (URS), leading to infections, obstruction and difficult stent removal. Potassium sodium hydrogen citrate may reduce encrustation by alkalinizing urine and increasing urinary citrate excretion. OBJECTIVES: To evaluate the effect of potassium sodium hydrogen citrate on DJ stent encrustation and to identify biochemical, clinical and microbiological predictors following ureteral stone surgery. METHODS: This retrospective comparative study included 110 adults undergoing URS with DJ stenting. Group A (n=55) received potassium sodium hydrogen citrate for 4 weeks, while Group B (n=55) served as control. Patients were followed for urinary parameters, complications and stent encrustation graded at removal. Multivariate regression and ROC analyses identified predictors of significant encrustation. RESULTS: Grade 0 encrustation was higher in Group A (65.45% vs. 36.36%; p=0.003). Urinary pH and citrate were higher in Group A (p<0.001). Low urinary citrate, low pH and positive urine culture predicted Grade ≥2 encrustation. Urinary citrate showed strongest predictive value (AUC 0.821). CONCLUSION: Potassium sodium hydrogen citrate reduces DJ stent encrustation severity by modifying urinary biochemistry and may enhance postoperative outcomes.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: